Radient Pharma names director of IR, biz development

TUSTIN, CA: Radient Pharmaceuticals Corporation, a developer of in vitro diagnostic cancer tests, has hired Dilek Mir as director of investor relations and business development.

TUSTIN, CA: Radient Pharmaceuticals Corporation, a developer of in vitro diagnostic cancer tests, has hired Dilek Mir as director of investor relations and business development.

In addition to IR and business development, Mir will also oversee new business, reimbursement strategy, and intellectual property strategy. Her IR experience spans 13 years, having advised and represented a number of publicly traded technology and healthcare companies. Mir also founded Polygot International, a privately owned language training firm in Moscow.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in